FDA Guidelines on Product Insert Updates

Ask AI

FDA CIRCULAR NO. 2011-002: FDA Guidelines on Product Insert Updates

Getting related questions...
What do you want to know about the law?
Your conversations and searches stay on your device. We do not store or track your activity on our servers. To know more about our privacy commitment see jur.ph/privacy Ask AI provides quick answers grounded in full case texts to avoid mistakes. Always verify with the original text.

Ask AI

Title Supreme Court: FDA Guidelines on Product Insert Updates

Law: Fda Circular No. 2011-002

Decision Date: Jun 2, 2011

Pharmaceutical companies must submit a certified true copy of their Certificate of Product Registration, previously approved inserts, clinical data, and a tabulated list of proposed changes for any revisions to package inserts, patient leaflets, and prescribing information, with strict compliance to FDA regulations to avoid sanctions for unapproved indications.

administrative law

pharmaceutical law

product registration

END